Bayer Group

Report of the Supervisory Board

Dr. Manfred Schneider
Dear stockholders:
During 2011 the Supervisory Board monitored the conduct of the company・スfs business by the Board of Management on a regular basis with the aid of detailed written and oral reports received from the Board of Management, and also acted in an advisory capacity. Inツaddition, the Chairman of the Supervisory Board and the Chairman of the Board of Management maintained a constant exchange of information. In this way the Supervisory Board was kept continuously informed about the company・スfs intended business strategy, corporate planning (including financial, investment and human resources planning), earnings performance, the state of the business and the situation in the company and the Group as a whole.
Where Board of Management decisions or actions required the approval of the Supervisory Board, whether by law or under the Articles of Incorporation or the rules of procedure, the draft resolutions were inspected by the members at the meetings of the full Supervisory Board, sometimes after preparatory work by the committees, or approved on the basis of documents circulated to the members. The Supervisory Board was involved in decisions of material importance to the company. We discussed at length the business trends described in the reports from the Board of Management and the prospects for the development of the Bayer Group as a whole, the individual organizational units and the principal affiliated companies in Germany and abroad.
Four meetings of the full Supervisory Board took place during 2011. No member of the Supervisory Board attended fewer than half of its meetings. The average attendance rate at the meetings exceeded 95 percent. The members of the Board of Management attended allツthe meetings of the Supervisory Board.

Principal topics discussed by the Supervisory Board

The deliberations of the Supervisory Board focused on questions relating to the strategies and business activities of the Group as a whole and of the subgroups. The discussions at the respective meetings in 2011 centered on various topics. At the February meeting, the Supervisory Board discussed the 2010 Annual Report and the agenda for the 2011 Annual Stockholders・スf Meeting. It also dealt at length with the Bayer Group・スfs risk management system, matters related to the Board of Management・スfs compensation, and a possible corporate acquisition. Finally, it approved an amendment to the Board of Management・スfs rules of procedure. At its meeting in April, the Supervisory Board reviewed the development of the business in the first quarter and discussed the imminent Annual Stockholders・スf Meeting.
At the September meeting, the Supervisory Board dealt with the renewal of Dr. Richard Pott・スfs appointment as a member of the Board of Management and Labor Director. Another main topic was the situation of the Group, including new developments regarding its strategy and competitive position. An additional point of discussion was the situation of the HealthCare subgroup. Following the meeting, an information and discussion forum took place on the role of the Supervisory Board in corporate acquisitions.
At the meeting in December 2011, the Board of Management presented its planning for the business operations, the finances and the asset and liability structure of the Bayer Group inツthe years 2012 through 2014. The Supervisory Board also deliberated on the existing systems of personnel development at Bayer. Finally, at this meeting the Supervisory Board resolved on the declaration of compliance with the German Corporate Governance Code and discussed matters concerning the Supervisory Board elections to be held at the Annual Stockholders・スf Meeting in 2012.
In July 2011 the Supervisory Board made one decision on the basis of documents circulated to the members. The decision related to the sale of a parcel of industrial land.

Committees of the Supervisory Board

The Supervisory Board has a Presidial Committee, an Audit Committee, a Human Resources Committee and a Nominations Committee. The current membership of the committees is shown on Supervisory Board.
Presidial Committee: This comprises the Chairman and Vice Chairman of the Supervisory Board along with a further stockholder representative and a further employee representative. The Presidial Committee serves primarily as the mediation committee pursuant to the German Codetermination Act. It has the task of submitting proposals to the Supervisory Board on the appointment of members of the Board of Management if the necessary two-thirds majority is not achieved in the first vote at a meeting of the full Supervisory Board. Certain decision-making powers in connection with capital measures, including the power to amend the Articles of Incorporation accordingly, have also been delegated to this committee.
On the basis of an authorization issued by the full Supervisory Board, the Presidial Committee made a written decision relating to the settlement of litigation concerning genetically modified rice. In 2011 the Presidial Committee was not required to convene in its capacity as the mediation committee pursuant to Section 27 Paragraph 3 of the German Codetermination Act.
Audit Committee: The Audit Committee comprises three stockholder representatives and three employee representatives. The Chairman of the Audit Committee in 2011, Dr. Klaus Sturany, satisfies the statutory requirements concerning the independence and the expertise in the field of accounting or auditing that a member of the Supervisory Board and the Audit Committee is required to possess. The Audit Committee meets regularly four times a year. Its tasks include examining the company・スfs financial reporting along with the financial statements of Bayer AG, the consolidated financial statements of the Bayer Group, the combined management report, the proposal for the use of the distributable profit of Bayer AG, and the interim financial statements and management reports of the Bayer Group, all of which are prepared by the Board of Management. On the basis of the auditor・スfs report on the audit of the financial statements of Bayer AG, the consolidated financial statements of the Bayer Group and the combined management report, the Audit Committee develops proposals concerning the approval of the statements by the full Supervisory Board. The Audit Committee is also responsible for the company・スfs relationship with the external auditor. The Audit Committee submits a proposal to the full Supervisory Board concerning the auditor・スfs appointment, prepares the awarding of the audit contract to the audit firm appointed by the Annual Stockholders・スf Meeting, suggests areas of focus for the audit and determines the auditor・スfs remuneration. It also monitors the independence, qualifications, rotation and efficiency of the auditor.
In addition, the Audit Committee oversees the company・スfs internal control system ? along with the procedures used to identify, track and manage risk ? and the internal audit system. It also deals with corporate compliance issues and discusses developments in this area at each of its meetings.
The Chairman of the Board of Management and the Chief Financial Officer regularly attended the meetings of the Audit Committee. The auditor was present at all the meetings, reporting in detail on the audit work and the audit reviews of the interim financial statements.
The meetings focused on a number of topics. At the February 2011 meeting, the Audit Committee discussed the risk report, which covered the risk management system, planning and market risks, legal risks, corporate compliance, the report on process and organizational risks and the internal control system, and the report by Corporate Auditing. At this meeting it also submitted a recommendation to the full Supervisory Board concerning the resolution to be put before the Annual Stockholders・スf Meeting on the appointment of the auditor of the financial statements. The April meeting was mainly devoted to the Bayer Group・スfs tax strategy, the yearly report of the Compliance Officer, and determining the main areas of focus for the audit of the 2011 financial statements. The meeting in July centered on the bidding for the audit of the financial statements, recent changes to the International Financial Reporting Standards, and the restructuring measures planned in the Group Accounting & Controlling function. The bidding for the audit of the financial statements was again a topic of discussion at the October meeting.
Human Resources Committee: On this committee, too, there is parity of representation between stockholders and employees. It consists of the Chairman of the Supervisory Board and three other Supervisory Board members. The Human Resources Committee prepares the personnel decisions of the full Supervisory Board, which resolves on appointments or dismissals of members of the Board of Management. The Human Resources Committee resolves on behalf of the Supervisory Board on the service contracts of the members of the Board of Management. However, it is the task of the full Supervisory Board to resolve on the total compensation of the individual members of the Board of Management and the respective compensation components, as well as to regularly review the compensation system on the basis of recommendations submitted by the Human Resources Committee. The Human Resources Committee also discusses the long-term succession planning for the Board of Management.
The Human Resources Committee convened on three occasions in 2011. The matters discussed at these meetings concerned the compensation of the members of the Board of Management, their service contracts, and the renewal of Dr. Richard Pott・スfs appointment as a member of the Board of Management and Labor Director.
Nominations Committee: This committee carries out preparatory work when an election of stockholder representatives to the Supervisory Board is to be held. It suggests suitable candidates for the Supervisory Board to propose to the Annual Stockholders・スf Meeting for election. The Nominations Committee comprises the Chairman of the Supervisory Board and the other stockholder representative on the Presidial Committee.
At one meeting and on several other occasions in 2011, in accordance with its responsibilities, the Nominations Committee discussed possible candidates for election to the Supervisory Board as stockholder representatives at the 2012 Annual Stockholders・スf Meeting.
The meetings and decisions of the committees, and especially the meetings of the Audit Committee, were prepared on the basis of reports and other information provided by the Board of Management. Reports on the committee meetings were presented at the meetings of the full Supervisory Board.

Corporate governance

The Supervisory Board dealt with the continuing development of corporate governance at Bayer, taking into account the May 26, 2010 version of the German Corporate Governance Code. In December 2011 the Board of Management and the Supervisory Board issued a new declaration of compliance, which is also reproduced in the Corporate Governance Report.

Financial statements and audits

The financial statements of Bayer AG were prepared according to the requirements of the German Commercial Code and Stock Corporations Act. The consolidated financial statements of the Bayer Group were prepared according to the German Commercial Code and the International Financial Reporting Standards (IFRS). The combined management report was prepared according to the German Commercial Code. The auditor, PricewaterhouseCoopers Aktiengesellschaft, Wirtschaftspr?fungsgesellschaft, Essen, has audited the financial statements of Bayer AG, the consolidated financial statements of the Bayer Group and the combined management report. The conduct of the audit is explained in the auditor・スfs reports. The auditor finds that Bayer has complied, as appropriate, with the German Commercial Code, the German Stock Corporations Act and/or the International Financial Reporting Standards endorsed by the European Union, and issues an unqualified opinion on the financial statements of Bayer AG and the consolidated financial statements of the Bayer Group. The financial statements of Bayer AG, the consolidated financial statements of the Bayer Group, the combined management report and the audit reports were submitted to all members of the Supervisory Board. They were discussed in detail by the Audit Committee and at a meeting of the full Supervisory Board. The auditor submitted a report on both occasions and was present during the discussions.
We examined the financial statements of Bayer AG, the proposal for distribution of the profit, the consolidated financial statements of the Bayer Group and the combined management report. We found no objections, thus we concur with the result of the audit.
We have approved the financial statements of Bayer AG and the consolidated financial statements of the Bayer Group prepared by the Board of Management. The financial statements of Bayer AG are thus confirmed. We are in agreement with the combined management report and, in particular, with the assessment of the future development of the enterprise. We also concur with the dividend policy and the decisions concerning earnings retention by the company. We assent to the proposal for distribution of the profit, which provides for payment of a dividend of ?1.65 per share.
The Supervisory Board would like to thank the Board of Management and all employees for their dedication and hard work in 2011.
Leverkusen, February 23, 2012
For the Supervisory Board:
Manfred Schneider
Dr. Manfred Schneider
Chairman
http://www.annualreport2011.bayer.com/en/report-of-the-supervisory-board.aspx

Copyright ? Bayer AG

Special Interest

Print page

Search

Download Center

Services

Full Year 2011 Results

Info

Last updated: February 28, 2012

テ・/a>